CAPTRUST Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41M | Buy |
676,445
+134,762
| +25% | +$7.86M | 0.07% | 225 |
|
|
2025
Q4 | $29.2M | Buy |
541,683
+84,161
| +18% | +$4.05M | 0.06% | 257 |
|
|
2025
Q3 | $20.6M | Sell |
457,522
-65,803
| -13% | -$3.07M | 0.04% | 313 |
|
|
2025
Q2 | $24.2M | Sell |
523,325
-20,036
| -4% | -$984K | 0.05% | 275 |
|
|
2025
Q1 | $33.1M | Buy |
543,361
+12,026
| +2% | +$701K | 0.08% | 203 |
|
|
2024
Q4 | $30.1M | Buy |
531,335
+63,229
| +14% | +$3.53M | 0.09% | 179 |
|
|
2024
Q3 | $24.2M | Buy |
468,106
+55,134
| +13% | +$2.59M | 0.07% | 206 |
|
|
2024
Q2 | $17.2M | Sell |
412,972
-35,757
| -8% | -$1.6M | 0.06% | 250 |
|
|
2024
Q1 | $24.3M | Sell |
448,729
-62,577
| -12% | -$3.19M | 0.09% | 183 |
|
|
2023
Q4 | $26.2M | Sell |
511,306
-51,523
| -9% | -$2.7M | 0.09% | 190 |
|
|
2023
Q3 | $32.7M | Buy |
562,829
+3,337
| +0.6% | +$204K | 0.12% | 146 |
|
|
2023
Q2 | $35.8M | Buy |
559,492
+17,369
| +3% | +$1.16M | 0.14% | 134 |
|
|
2023
Q1 | $37.6M | Buy |
542,123
+27,024
| +5% | +$1.91M | 0.17% | 126 |
|
|
2022
Q4 | $37.1M | Buy |
515,099
+16,888
| +3% | +$1.27M | 0.19% | 120 |
|
|
2022
Q3 | $35.4M | Buy |
498,211
+116,613
| +31% | +$8.46M | 0.21% | 101 |
|
|
2022
Q2 | $29.6M | Buy |
381,598
+47,642
| +14% | +$3.63M | 0.19% | 121 |
|
|
2022
Q1 | $24.6M | Buy |
333,956
+28,924
| +9% | +$1.94M | 0.16% | 141 |
|
|
2021
Q4 | $19M | Buy |
305,032
+25,663
| +9% | +$1.51M | 0.13% | 160 |
|
|
2021
Q3 | $16.7M | Buy |
279,369
+42,855
| +18% | +$2.82M | 0.14% | 162 |
|
|
2021
Q2 | $15.8M | Sell |
236,514
-4,949
| -2% | -$323K | 0.15% | 148 |
|
|
2021
Q1 | $15.4M | Buy |
241,463
+6,616
| +3% | +$412K | 0.17% | 137 |
|
|
2020
Q4 | $14.7M | Buy |
234,847
+2,002
| +0.9% | +$123K | 0.19% | 123 |
|
|
2020
Q3 | $14M | Buy |
232,845
+6,630
| +3% | +$399K | 0.23% | 113 |
|
|
2020
Q2 | $13.4M | Buy |
226,215
+21,052
| +10% | +$1.26M | 0.22% | 115 |
|
|
2020
Q1 | $11.2M | Buy |
205,163
+12,589
| +7% | +$769K | 0.25% | 105 |
|
|
2019
Q4 | $12.2M | Buy |
192,574
+109,531
| +132% | +$6.27M | 0.19% | 135 |
|
|
2019
Q3 | $4.21M | Buy |
83,043
+947
| +1% | +$44.5K | 0.15% | 134 |
|
|
2019
Q2 | $3.72M | Buy |
82,096
+5,975
| +8% | +$278K | 0.14% | 138 |
|
|
2019
Q1 | $3.63M | Buy |
76,121
+2,882
| +4% | +$144K | 0.15% | 126 |
|
|
2018
Q4 | $3.81M | Sell |
73,239
-2,839
| -4% | -$153K | 0.2% | 97 |
|
|
2018
Q3 | $4.72M | Buy |
76,078
+33,340
| +78% | +$1.98M | 0.21% | 84 |
|
|
2018
Q2 | $2.37M | Buy |
42,738
+10,778
| +34% | +$582K | 0.13% | 103 |
|
|
2018
Q1 | $1.98M | Sell |
31,960
-9,893
| -24% | -$636K | 0.12% | 111 |
|
|
2017
Q4 | $2.56M | Buy |
41,853
+39,423
| +1,622% | +$2.47M | 0.16% | 98 |
|
|
2017
Q3 | $155K | Buy |
+2,430
| New | +$142K | 0.01% | 218 |
|
Other funds holding BMY
VCM
VPM
CAPTRUST Financial Advisors's BMY Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, buying an estimated $7.86M and bringing the position to 676,445 shares worth $41M. The position accounts for 0.07% of the portfolio, ranked #225.
CAPTRUST Financial Advisors first reported a position in BMY in Q3 2017 and has held it in 35 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- CAPTRUST Financial Advisors held 676,445 shares of Bristol-Myers Squibb worth $41M as of Q1 2026.
- CAPTRUST Financial Advisors bought 134,762 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.86M.
- Bristol-Myers Squibb made up 0.07% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #225 holding.
- CAPTRUST Financial Advisors first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 35 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.